Q92731 (ESR2_HUMAN) Homo sapiens (Human)

Estrogen receptor beta UniProtKBInterProSTRINGInteractive Modelling

530 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9); 1 identical sequence: Homo sapiens: Q7LCB3

Available Structures

37 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR P… Heteromer
Q9HCD5;
262-502
KB0;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 Heteromer
Q15788;
263-501
338;
Assess
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 Heteromer
Q15788;
263-500
555;
Assess
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-i… Heteromer
Q15788;
263-500
789;
Assess
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain Heteromer
Q15788;
262-498
EST;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with S-DPN Heteromer
Q15788;
263-498
I0K;
Assess
Stapled peptide bound to Estrogen Receptor Beta Heteromer
Q15596;
263-497
YJD;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 Heteromer
Q15788;
263-497
697;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 Heteromer
Q15788;
263-497
797;
Assess
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen… Heteromer
Q15788;
263-497
4NA;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
264-497
W23;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
264-497
W14;
Assess
Crystal structure of estrogen receptor beta ligand binding domain Heteromer
Q15788;
264-497
EST;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788;
264-497
WV7;
Assess
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen recept…homo-2-mer260-501
OHT;
Assess
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonisthomo-2-mer260-501
JJ3;
Assess
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEINhomo-2-mer260-500
GEN;
Assess
Human estrogen receptor beta ligand-binding domain in complex with compound 45homo-2-mer260-500
FBR;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer260-500
DC8;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer260-500
3AS;
Assess
Crystal Structure of ER beta bound to Estradiolhomo-2-mer262-501
EST;
Assess
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of…homo-2-mer260-498
I0G;
Assess
Sulfonamides as selective Estrogen Receptor beta Agonists.homo-2-mer260-498
SU4;SO4;
Assess
Crystal structure of estrogen receptor beta complexed with way-202196homo-2-mer263-500
196;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244homo-2-mer263-500
244;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041homo-2-mer263-500
041;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-2-(2-chloro-4-hydroxyphenyl)…homo-2-mer263-498
I1M;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-3-(2-chloro-4-hydroxyphenyl)…homo-2-mer263-498
I1I;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-3-(2-chloro-4-hydroxyphenyl)…homo-2-mer263-498
I1D;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-2-(2-chloro-4-hydroxyphenyl)…homo-2-mer263-498
I2B;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEINhomo-2-mer263-497
GEN;
Assess
Crystal Structure of Estrogen Receptor beta complexed with CL-272homo-2-mer263-497
272;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12…monomer261-501
ETC;
Assess
Estrogen Receptor beta with Selective Triazine Modulatormonomer261-500
MON;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer261-498
EST;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer262-498
EST;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397monomer263-497
397;
Assess

11 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5uan.1.Bmonomer0.59148-496
ZN;27.40
Assess
7kw7.1.Fmonomer0.59253-501
30.21
Assess
4nqa.2.Amonomer0.59142-498
ZN;32.93
Assess
5uan.1.Amonomer0.58147-497
ZN;32.93
Assess
4iqr.1.Amonomer0.58147-497
ZN;29.15
Assess
4nqa.1.Amonomer0.58147-496
ZN;34.88
Assess
3dzy.1.Amonomer0.57146-495
ZN;32.42
Assess
4iqr.2.Bmonomer0.57147-497
ZN;29.15
Assess
4nqa.1.Bmonomer0.57144-496
ZN;25.58
Assess
4nqa.2.Bmonomer0.57144-497
ZN;25.58
Assess
3dzy.1.Bmonomer0.55146-497
ZN;23.10
Assess

65 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27kw7.1.Fmonomer0.59253-477
31.86
Assess
Isoform 25uan.1.Bmonomer0.58148-490
ZN;26.99
Assess
Isoform 24nqa.1.Amonomer0.58142-490
ZN;31.37
Assess
Isoform 24iqr.2.Amonomer0.57147-491
ZN;29.62
Assess
Isoform 25uan.1.Amonomer0.57147-490
ZN;31.37
Assess
Isoform 23e00.1.Amonomer0.56146-490
ZN;30.82
Assess
Isoform 24iqr.2.Bmonomer0.56147-491
ZN;29.62
Assess
Isoform 24nqa.1.Bmonomer0.56143-491
ZN;25.07
Assess
Isoform 24nqa.2.Bmonomer0.56143-491
ZN;25.07
Assess
Isoform 23dzu.1.Bmonomer0.55146-491
23.88
Assess
Isoform 35uan.1.Bmonomer0.54149-321
ZN;36.31
Assess
Isoform 33dzy.1.Amonomer0.53146-322
ZN;33.75
Assess
Isoform 34iqr.2.Bmonomer0.53147-322
ZN;31.41
Assess
Isoform 45uan.1.Bmonomer0.59148-482
ZN;26.73
Assess
Isoform 47kw7.1.Fmonomer0.59253-481
32.19
Assess
Isoform 44nqa.2.Amonomer0.58142-483
ZN;32.17
Assess
Isoform 44iqr.2.Amonomer0.57147-480
ZN;28.48
Assess
Isoform 44iqr.1.Bmonomer0.57147-480
ZN;28.48
Assess
Isoform 44nqa.2.Bmonomer0.57143-482
ZN;26.14
Assess
Isoform 44nqa.1.Bmonomer0.57143-482
ZN;26.14
Assess
Isoform 43dzy.1.Bmonomer0.57146-474
ZN;23.20
Assess
Isoform 45uan.1.Amonomer0.56147-483
ZN;32.17
Assess
Isoform 43dzy.1.Amonomer0.56146-483
ZN;31.61
Assess
Isoform 51qkn.1.Bhomo-2-mer0.78262-467
92.49
Assess
Isoform 57kw7.1.Fmonomer0.59253-475
31.75
Assess
Isoform 54iqr.1.Amonomer0.57147-474
ZN;29.29
Assess
Isoform 54nqa.1.Bmonomer0.57143-474
ZN;24.84
Assess
Isoform 54iqr.2.Bmonomer0.57147-474
ZN;29.29
Assess
Isoform 55uan.1.Bmonomer0.56149-480
ZN;29.51
Assess
Isoform 54nqa.1.Amonomer0.56147-407
ZN;37.30
Assess
Isoform 54nqa.2.Bmonomer0.56143-474
ZN;24.84
Assess
Isoform 53dzy.1.Amonomer0.56147-407
ZN;37.30
Assess
Isoform 53dzu.1.Bmonomer0.56146-476
23.36
Assess
Isoform 55uan.1.Amonomer0.55147-407
ZN;37.30
Assess
Isoform 65uan.1.Bmonomer0.60148-470
ZN;27.12
Assess
Isoform 67kw7.1.Fmonomer0.59253-470
31.94
Assess
Isoform 64nqa.2.Amonomer0.58142-470
ZN;32.45
Assess
Isoform 64iqr.2.Amonomer0.58147-470
ZN;29.35
Assess
Isoform 64nqa.1.Bmonomer0.58143-470
ZN;25.47
Assess
Isoform 64nqa.2.Bmonomer0.58143-470
ZN;25.47
Assess
Isoform 64iqr.2.Bmonomer0.58147-470
ZN;29.35
Assess
Isoform 65uan.1.Amonomer0.57147-470
ZN;32.45
Assess
Isoform 63dzy.1.Amonomer0.57146-470
ZN;32.23
Assess
Isoform 63dzu.1.Bmonomer0.56146-470
23.49
Assess
Isoform 74nqa.2.Bmonomer0.53144-406
ZN;27.38
Assess
Isoform 72j7x.1.Amonomer0.52318-407
87.13
Assess
Isoform 74nqa.1.Amonomer0.52142-405
ZN;31.87
Assess
Isoform 74nqa.1.Bmonomer0.51144-405
ZN;27.38
Assess
Isoform 73dzu.1.Amonomer0.51146-404
ZN;32.11
Assess
Isoform 84iqr.2.Amonomer0.54147-365
ZN;33.67
Assess
Isoform 84nqa.1.Bmonomer0.54144-364
ZN;28.96
Assess
Isoform 84iqr.2.Bmonomer0.53147-365
ZN;33.67
Assess
Isoform 84nqa.2.Bmonomer0.53144-364
ZN;28.96
Assess
Isoform 83dzy.1.Bmonomer0.53146-362
ZN;26.73
Assess
Isoform 83dzy.1.Amonomer0.51147-371
ZN;39.61
Assess
Isoform 95uan.1.Bmonomer0.60148-472
ZN;26.54
Assess
Isoform 97kw7.1.Fmonomer0.59253-473
31.63
Assess
Isoform 94iqr.1.Amonomer0.58147-472
ZN;29.15
Assess
Isoform 94nqa.1.Amonomer0.58147-407
ZN;37.30
Assess
Isoform 94nqa.2.Bmonomer0.58143-471
ZN;26.02
Assess
Isoform 94iqr.2.Bmonomer0.58147-472
ZN;29.15
Assess
Isoform 94nqa.1.Bmonomer0.57143-471
ZN;26.02
Assess
Isoform 93dzy.1.Amonomer0.57147-407
ZN;37.30
Assess
Isoform 93dzu.1.Bmonomer0.57146-471
23.42
Assess
Isoform 95uan.1.Amonomer0.56147-407
ZN;37.30
Assess